{ "labelLang" : "hun", "responseDate" : "2024-03-29 14:37", "content" : { "otype" : "JournalArticle", "mtid" : 26222201, "status" : "ADMIN_APPROVED", "published" : true, "comment" : "N1 : Chemicals/CASasoprisnil, 163883-84-9; mifepristone, 84371-65-3; onapristone, 96346-61-1; promegestone, 34184-77-5", "unhandledTickets" : 0, "oldTimestamp" : "2018-10-01T22:02:23.000+0000", "deleted" : false, "oldId" : 16222201, "lastRefresh" : "2020-04-06T16:21:17.764+0000", "lastModified" : "2018-10-01T22:02:23.000+0000", "created" : "2013-07-08T08:55:37.000+0000", "creator" : { "otype" : "Author", "mtid" : 10009292, "link" : "/api/author/10009292", "label" : "Németh Gábor László (Szülészet, nőgyógyászat)", "familyName" : "Németh", "givenName" : "Gábor László", "published" : true, "oldId" : 10009292, "snippet" : true }, "duplumSearchResult" : { "id" : 2771839, "creationDate" : "2019-12-23T12:24:09.334+0000", "startDate" : "2019-12-23T12:24:09.065+0000", "creator" : { "otype" : "Admin", "mtid" : 565, "link" : "/api/admin/565", "label" : "WoS import (admin)", "familyName" : "WoS", "givenName" : "import", "published" : true, "snippet" : true } }, "duplumRole" : "DUPLUM", "lastDuplumSearch" : "2019-12-23T12:24:09.065+0000", "adminApproved" : "2016-11-29T11:29:34.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10037098, "link" : "/api/admin/10037098", "label" : "Csúcs Erika (SZTE admin5 ÁOK Szülészeti és Nőgyógyászati Klinika)", "familyName" : "Csúcs", "givenName" : "Erika", "published" : true, "oldId" : 10037098, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10006, "link" : "/api/language/10006", "label" : "Francia", "name" : "Francia", "nameEng" : "French", "published" : true, "oldId" : 6, "snippet" : true } ], "firstAuthor" : "Chabbert-Buffet, N", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 61823853, "link" : "/api/authorship/61823853", "label" : "Chabbert-Buffet, N", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Chabbert-Buffet", "givenName" : "N", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 126597563, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 61823854, "link" : "/api/authorship/61823854", "label" : "Dvourétchenskaia, O", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Dvourétchenskaia", "givenName" : "O", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 126597564, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 61823855, "link" : "/api/authorship/61823855", "label" : "Jablonski, C", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Jablonski", "givenName" : "C", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 126597565, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 61823856, "link" : "/api/authorship/61823856", "label" : "Bouchard, P", "listPosition" : 4, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Bouchard", "givenName" : "P", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 126597566, "snippet" : true } ], "title" : "Clinical use of selective progesterone receptor modulators", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 11803519, "link" : "/api/publicationidentifier/11803519", "label" : "Scopus: 20544455577", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "NO", "idValue" : "20544455577", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-20544455577", "published" : false, "oldId" : 13783413, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 10050040, "link" : "/api/journal/10050040", "label" : "Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie 1295-9359", "pIssn" : "1295-9359", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : false, "scopusIndexed" : true, "hungarian" : false, "published" : true, "oldId" : 10050040, "snippet" : true }, "volume" : "7", "issue" : "2", "firstPage" : "100", "lastPage" : "108", "firstPageOrInternalIdForSort" : "100", "pageLength" : 9, "publishedYear" : 2005, "digital" : null, "printed" : null, "sourceYear" : 2013, "packet" : "(Hulesch Helga (SZTE admin5); 2013.07.08. 10:54:58)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2020-04-06", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "referenceList" : "Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., Hulley, S.B., Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics (1998) Control Clin Trials, 19, pp. 314-335; \n\nHulley, S., Grady, D., Bush, T., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (1998) JAMA, 280, pp. 605-613. , Heart and Estrogen/progestin Replacement Study (HERS) Research Group; \n\nDesign of the Women's Health Initiative clinical trial and observational study (1998) Control Clin Trials, 19, pp. 61-109. , The Women's Health Initiative Study Group; \n\nLuukkainen, T., Issues to debate on the Women's Health Initiative: Failure of estrogen plus progestin therapy for prevention of breast cancer risk (2003) Hum Reprod, 18, pp. 1559-1561; \n\nChabbert-Buffeta, N., Skinner, D.C., Caraty, A., Bouchard, P., Neuroendocrine effects of progesterone (2000) Steroids, 65, pp. 613-620; \n\nChabbert-Buffet, N., Bouchard, P., The normal human menstrual cycle (2002) Rev Endocr Metab Disord, 3, pp. 173-183; \n\nBaird, D.T., Glasier, A.F., Science, medicine, and the future. Contraception (1999) BMJ, 319, pp. 969-972; \n\nLeonhardt, S.A., Edwards, D.P., Mechanism of action of progesterone antagonists (2002) Exp Biol Med (Maywood), 227, pp. 969-980; \n\nDe Ziegler, D., Fanchin, R., Freitas, S., Bouchard, P., The hormonal control of endometrial receptivity in egg donation and IVF: From a two to a multi-player senario (1993) Acta Eur Fertil, 24, pp. 147-153; \n\nConneely, O.M., Jericevic, B.M., Lydon, J.P., Progesterone receptors in mammary gland development and tumorigenesis (2003) J Mammary Gland Biol Neoplasia, 8, pp. 205-214; \n\nIsmail, P.M., Amato, P., Soyal, S.M., Progesterone involvement in breast development and tumorigenesis-as revealed by progesterone receptor \"knockout\" and \"knockin\" mouse models (2003) Steroids, 68, pp. 779-787; \n\nAnderson, E., Ovarian steroids and control of proliferation in the normal human breast (2001) Breast, 10, pp. 273-278; \n\nMilgrom, E., Atger, M., Baulieu, E.E., Progesterone in uterus and plasma. IV. Progesterone receptor(s) in guinea pig uterus cytosol (1970) Steroids, 16, pp. 741-754; \n\nSmith, D.F., Toft, D.O., Steroid receptors and their associated proteins (1993) Mol Endocrinol, 7, pp. 4-11; \n\nBeato, M., Sanchez-Pacheco, A., Interaction of steroid hormone receptors with the transcription initiation complex (1996) Endocr Rev, 17, pp. 587-609; \n\nConneely, O.M., Lydon, J.P., Progesterone receptors in reproduction: Functional impact of the A and B isoforms (2000) Steroids, 65, pp. 571-577; \n\nLydon, J.P., DeMayo, F.J., Funk, C.R., Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities (1995) Genes Dev, 9, pp. 2266-2278; \n\nConneely, O.M., Mulac-Jericevic, B., Lydon, J.P., De Mayo, F.J., Reproductive functions of the progesterone receptor isoforms: Lessons from knock-out mice (2001) Mol Cell Endocrinol, 179, pp. 97-103; \n\nShyamala, C., Yang, X., Silberstein, C., Barcellos-Hoff, M.H., Dale, E., Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands (1998) Proc Natl Acad Sci USA, 95, pp. 696-701; \n\nMulac-Jericevic, B., Lydon, J.P., DeMayo, F.J., Conneely, O.M., Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform (2003) Proc Natl Acad Sci USA, 100, pp. 9744-9749; \n\nMulac-Jericevic, B., Mullinax, R.A., DeMayo, F.J., Lydon, J.P., Conneely, O.M., Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform (2000) Science, 289, pp. 1751-1754; \n\nAmar, L., Bouchard, P., Selective progesterone receptor modulators (2002) Ref Gynecol Obstet, 10, pp. 9-11; \n\nGiannoukos, C., Szapary, D., Smith, C.L., Meeker, J.E., Simons Jr., S.S., New antiprogestins with partial agonist activity: Potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties (2001) Mol Endocrinol, 15, pp. 255-270; \n\nWagner, B.L., Pollio, C., Leonhardt, S., 16 Alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity (1996) Proc Natl Acad Sci USA, 93, pp. 8739-8744; \n\nSathya, C., Jansen, M.S., Nagel, S.C., Cook, C.E., McDonnell, D.P., Identification and characterization of novel estrogen receptor-beta-sparing antiprogestins (2002) Endocrinology, 143, pp. 3071-3082; \n\nGiangrande, P.H., McDonnell, D.P., The A and B isoforms of the human progesterone receptor: Two functionally different transcription factors encoded by a single gene (1999) Recent Prog Horm Res, 54, pp. 291-313. , discussion 313-4; \n\nGiangrande, P.H., Kimbrel, E.A., Edwards, D.P., McDonnell, D.P., The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding (2000) Mol Cell Biol, 20, pp. 3102-3115; \n\nWagner, B.L., Norris, J.D., Knotts, T.A., Weigel, N.L., McDonnell, D.P., The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor (1998) Mol Cell Biol, 18, pp. 1369-1378; \n\nRowan, B.C., O'Malley, B.W., Progesterone receptor coactivators (2000) Steroids, 65, pp. 545-549; \n\nJackson, T.A., Richer, J.K., Bain, D.L., Takimoto, C.S., Tung, L., Horwitz, K.B., The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT (1997) Mol Endocrinol, 11, pp. 693-705; \n\nLiu, Z., Auboeuf, D., Wong, J., Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486 (2002) Proc Natl Acad Sci USA, 99, pp. 7940-7944; \n\nSmith, C., O'Malley, B.W., Coregulator functions: A key to understanding tissue specificity of selective recpetor modulators (2004) Endocr Rev, 25, pp. 45-71; \n\nPhilibert, D., Deraedt, R., Teutsch, C., RU 38486: A potent antiglucocorticoid in vivo (1981) The VII International Congress of Pharmacology, , Tokyo, Japan; \n\nGravanis, A., Schaison, C., George, M., Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women (1985) J Clin Endocrinol Metab, 60, pp. 156-163; \n\nSpitz, I.M., Progesterone antagonists and progesterone receptor modulators (2003) Expert Opin Investig Drugs, 12, pp. 1693-1707; \n\nElger, W., Bartley, J., Schneider, B., Kaufmann, C., Schubert, C., Chwalisz, K., Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity (2000) Steroids, 65, pp. 713-723; \n\nForce on Post - Ovulatory Methods of Fertility Regulation. Termination of Early Human Pregnancy with RU 486 (Mifepristone) and the prostaglandin analogue sulprostone: A multicenter, randomized comparison between two treatment regimens (1989) Hum Reprod, 4, pp. 718-725; \n\nChristin-Maitre, S., Bouchard, P., Spitz, I.M., Medical termination of pregnancy (2000) New Engl J Med, 342, pp. 946-956; \n\nCreinin, M.D., Pymar, H.C., Schwartz, J.L., Mifepristone 100 mg in abortion regimens (2001) Obstet Gynecol, 98, pp. 434-439; \n\nSchaff, E.A., Stadalius, L.S., Eisinger, S.H., Franks, P., Vaginal misoprostol administered at home after mifepristone (RU486) for abortion (1997) J Fam Pract, 44, pp. 353-360; \n\nSchaff, E.A., Fielding, S.L., Westhoff, C., Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion (2001) Contraception, 64, pp. 81-85; \n\nMenstrual regulation by mifepristone plus prostaglandin: Results from a multicentre trial (1995) Hum Reprod, 10, pp. 308-314; \n\nNeilson, J.P., Mifepristone for induction of labour (Cochrane Review) (2003) The Cochrane Library, (1). , Oxford: Update Software; \n\nBaird, D.T., Thong, K.J., Hall, C., Cameron, S.T., Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days (1995) Hum Reprod, 10, pp. 2270-2276; \n\nCouzinet, B., Young, J., Kujas, M., The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women (1999) J Clin Endocrinol Metab, 84, pp. 4191-4196; \n\nSpitz, I.M., Shoupe, D., Sitruk-Ware, R., Mishell Jr., D.R., Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women (1989) J Reprod Fertil Suppl, 37, pp. 253-260; \n\nLiu, J.H., Garzo, C., Morris, S., Stuenkel, C., Ulmann, A., Yen, S.S., Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486 (1987) J Clin Endocrinol Metab, 65, pp. 1135-1140; \n\nLuukkainen, T., Heikinheimo, O., Haukkamaa, M., Lahteenmaki, P., Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486 (1988) Fertil Steril, 49, pp. 961-963; \n\nBaird, D.T., Brown, A., Critchley, H.O., Williams, A.R., Lin, S., Cheng, L., Effect of long-term treatment with low-dose mifepristone on the endometrium (2003) Hum Reprod, 18, pp. 61-68; \n\nBrown, A., Williams, A., Cameron, S., Morrow, S., Baird, D.T., A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruption (2003) Contraception, 68, pp. 203-209; \n\nQiu, X., Sun, X., Christow, A., Stabi, B., Gemzell-Danielsson, K., Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviduct (2003) Fertil Steril, 80, pp. 776-782; \n\nCameron, S.T., Thong, K.J., Baird, D.T., Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth (1995) Clin Endocrinol (Oxf), 43, pp. 407-414; \n\nLedger, W.L., Sweeting, V.M., Hillier, H., Baird, D.T., Inhibition of ovulation by low-dose mifepristone (RU 486) (1992) Hum Reprod, 7, pp. 945-950; \n\nBrown, A., Cheng, L., Lin, S., Baird, D.T., Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double-blind randomized control trial of 2 and 5 mg per day for 120 days (2002) J Clin Endocrinol Metab, 87, pp. 63-70; \n\nCroxatto, H.B., Kovacs, L., Massai, R., Effects of long-term low-dose mifepristone on reproductive function in women (1998) Hum Reprod, 13, pp. 793-798; \n\nBatista, M.C., Cartledge, T.P., Zellmer, A.W., Nieman, L.K., Merriam, C.R., Loriaux, D.L., Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation (1992) J Clin Endocrinol Metab, 74, pp. 565-570; \n\nChwalisz, K., Elger, W., McCrary, K., Beckman, P., Larsen, L., Reversible suppression of menstruation in normal women irrespective of the effect on ovulation with the novel selective progesterone receptor modulator (SPRM) J 867 (2002) J Soc Gynecol Investig, 9. , abstract 49; \n\nGemzell-Danielsson, K., Mandl, I., Marions, L., Mechanisms of action of mifepristone when used for emergency contraception (2003) Contraception, 68, pp. 471-476; \n\nPsychoyos, A., Nikas, C., Sarantis, L., Gravanis, A., Hormonal antiimplantation agents: Antiprogestins (1995) Hum Reprod, 10, pp. 140-150; \n\nComparison of three single doses of mifepristone as emergency contraception: A randomised trial (1999) Lancet, 353, pp. 697-702. , Task Force on Postovulatory Methods of Fertility Regulation; \n\nXiao, B.L., Von Hertzen, H., Zhao, H., Effects of mifepristone of different doses on emergency contraception, a randomized double-blind study (2003) Zhonghua Yi Xue Za Zhi, 83, pp. 813-818; \n\nRandomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception (1998) Lancet, 352, pp. 428-433. , Task Force on Postovulatory Methods of Fertility Regulation; \n\nVon Hertzen, H., Research on mifepristone and levonorgestrel in comparison with the Yuzpe regimen (1998) J Am Med Womens Assoc, 53, pp. 222-224; \n\nVon Hertzen, H., Piaggio, G., Ding, J., Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomised trial (2002) Lancet, 360, pp. 1803-1810; \n\nGemzell-Danielsson, K., Van Heusden, A.M., Killick, S.R., Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen (2002) Hum Reprod, 17, pp. 2588-2593; \n\nPassaro, M.D., Piquion, J., Mullen, N., Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women (2003) Hum Reprod, 18, pp. 1820-1827; \n\nGlasier, A.F., Wang, H., Davie, J.E., Kelly, R.W., Critchley, H.O., Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: A pilot study (2002) Fertil Steril, 77, pp. 366-372; \n\nCheng, L., Zhu, H., Wang, A., Ren, F., Chen, J., Glasier, A., Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel (2000) Hum Reprod, 15, pp. 1969-1972; \n\nEisinger, S.H., Meldrum, S., Fiscella, K., Le Roux, H.D., Guzick, D.S., Low-dose mifepristone for uterine leiomyomata (2003) Obstet Gynecol, 101, pp. 243-250; \n\nChwalisz, K.H., Selective progesterone receptor modulators (SPRMs) in reproductive endocrinology and gynecological therapy (2003) 5th Annual Meeting, 5, pp. 1-21. , Society for Gynecologic Investigation; \n\nKettel, L.M., Murphy, A.A., Morales, A.J., Ulmann, A., Baulieu, E.E., Yen, S.S., Treatment of endometriosis with the antiprogesterone mifepristone (RU486) (1996) Fertil Steril, 65, pp. 23-28; \n\nKettel, L.M., Murphy, A.A., Morales, A.J., Yen, S.S., Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486) (1998) Am J Obstet Gynecol, 178, pp. 1151-1156; \n\nEisinger, S.H., Meldrum, S., Fiscella, K., Le Roux, H.D., Guzick, D.S., Low-dose mifepristone for uterine leiomyomata (2003) Obstet Gynecol, 101, pp. 243-250; \n\nSteinauer, J., Pritts, E.A., Jackson, R., Jacoby, A.F., Systematic review of mifepristone for the treatment of uterine leiomyomata (2004) Obstet Gynecol, 103, pp. 1331-1336; \n\nMulac Jericevic, B., Mullinax, R.A., DeMayo, F.J., Lydon, J.P., Conneely, O.M., Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform (2000) Science, 289, pp. 1751-1754", "hasCitationDuplums" : false, "userChangeableUntil" : "2016-11-29T11:29:34.000+0000", "publishDate" : "2016-11-29T11:29:24.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 1, "ownerInstituteCount" : 3, "directInstituteCount" : 0, "authorCount" : 4, "contributorCount" : 0, "hasQualityFactor" : false, "link" : "/api/publication/26222201", "label" : "Chabbert-Buffet N et al. Clinical use of selective progesterone receptor modulators. (2005) Medecine Therapeutique Medecine de la Reproduction, Gynecologie et Endocrinologie 1295-9359 7 2 100-108", "template" : "